Biogen
BIIB
#665
Rank
โ‚น3.419 T
Marketcap
โ‚น23,130
Share price
-1.37%
Change (1 day)
54.70%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

EPS for Biogen (BIIB)

EPS in 2026 (TTM): โ‚น222.45

According to Biogen's latest financial reports the company's current EPS (TTM) is โ‚น220.14. In 2025 the company made an earnings per share (EPS) of โ‚น823.66 a decrease over its 2024 EPS that were of โ‚น1,047.

EPS history for Biogen from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น222.45-72.99%
2025โ‚น823.66-21.3%
2024โ‚น1,04739.73%
2023โ‚น749.04-61.74%
2022โ‚น1,958101.25%
2021โ‚น972.91-57.43%
2020โ‚น2,285-22.27%
2019โ‚น2,94045.66%
2018โ‚น2,01981.39%
2017โ‚น1,113-29.62%
2016โ‚น1,58110.28%
2015โ‚น1,43423.65%
2014โ‚น1,15957.94%
2013โ‚น734.1135.92%
2012โ‚น540.0913.53%
2011โ‚น475.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น623.09 183.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น66.23-69.92%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น545.84 147.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,621 636.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น184.74-16.08%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
-โ‚น289.17-231.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น549.42 149.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-โ‚น4,693-2,231.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น185.14-15.90%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Bio-Rad Laboratories
BIO
โ‚น3,560 1,516.95%๐Ÿ‡บ๐Ÿ‡ธ USA